期刊
PULMONARY PHARMACOLOGY & THERAPEUTICS
卷 14, 期 3, 页码 211-219出版社
ACADEMIC PRESS LTD
DOI: 10.1006/pupt.2001.0283
关键词
NF-kappa B; AP-1; glucocorticoid receptor; asthma; leukocytes
Glucocorticoids are the most effective antiinflammatory drugs used in the treatment of asthma, They act by binding to a specific receptor (GR) that, upon activation, translocates to the nucleus and either increases (transactivates) or decreases (transrepresses) gene expression. Inhibition of pro-inflammatory transcription factors such as activator protein (AP)-1, signal transducers and activators of transcription (STATs), nuclear factor of activated T cells (NF-AT) and nuclear factor (NF)-kappaB is thought to be a major action of glucocorticoids, Acetylation of histones allows unwinding of the local DNA structure and enables RNA polymerase II to enhance gene transcription. Histone acetylation is regulated by a balance between the activity of histone acetyltransferases (HATs) and histone deacetylases (HDACs), GR acts as a direct inhibitor of NF-KB-induced HAT activity and also by recruiting HDAC2 to the NF-kappaB/HAT complex. A sub-group of patients with glucocorticoid-insensitive asthma have an inability to induce histone acetylation in response to dexamethasone suggesting reduced expression of a GR-specific HAT. This suggests that pharmacological manipulation of specific histone acetylation status is a potentially useful approach for the treatment of inflammatory diseases. Identification of the precise mechanism by which activated GR recruits HDAC2 may reveal new targets for the development of drugs that may dissociate the antiinflammatory actions of glucocorticoids from their side effects that are largely due to gene induction. (C) 2001 Academic Press.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据